Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients

Cytomegalovirus (CMV) infection is a significant complication after kidney transplantation. We examined the ability of RG7667, a combination of two monoclonal antibodies, to prevent CMV infection in high-risk kidney transplant recipients in a randomized, double-blind, placebo-controlled trial. CMV-s...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Antimicrob Agents Chemother
Hlavní autoři: Ishida, Julie H., Patel, Anita, Mehta, Aneesh K., Gatault, Philippe, McBride, Jacqueline M., Burgess, Tracy, Derby, Michael A., Snydman, David R., Emu, Brinda, Feierbach, Becket, Fouts, Ashley E., Maia, Mauricio, Deng, Rong, Rosenberger, Carrie M., Gennaro, Lynn A., Striano, Natalee S., Liao, X. Charlene, Tavel, Jorge A.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2017
Témata:
Antiviral Agents
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5278717/
https://ncbi.nlm.nih.gov/pubmed/27872061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01794-16
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky